Renowned pathologist warns about possible consequences of silicone use in breast reconstruction

NewsGuard 100/100 Score

The public and the press were electrified in early May when superstar actress and filmmaker Angelina Jolie announced in a New York Times opinion piece that she had received a double mastectomy and follow-up breast reconstruction. Renowned pathologist Rahim Karjoo M.D ., F.C.A.P., F.A.S.C.P., is an expert in the diagnosis and treatment of Morgellons disease, an illness that is little known or acknowledged in the mainstream medical community. While Dr. Karjoo applauds Ms. Jolie's brave decision to go public with her decision to remove her breasts rather than face an 87% chance of a cancer, he is concerned about possible unintended consequences relating to the silicone often used as implants in breast reconstruction.

"I have reviewed hundreds of cases of women suffering from medical, clinical, and histopathogical problems due to the toxicity of silicone and silicone dioxide; the dangers are very real," said Dr. Karjoo.  The distinguished physician and researcher has been working tirelessly on behalf of patients seeking a Morgellons cure. A great deal of Dr. Karjoo's work has revolved around the connection he sees between the condition commonly known as Morgellons disease and silicone as well as silica dust, both endogenous (internal, i.e., beneath the skin) and exogenous (external), which have been just as insect-killing pesticides. Dr. Karjoo therefore strongly recommends that women who are receiving breast reconstruction surgery avoid putting foreign products into their body and instead use an autologous procedure, which uses tissue from the surrounding area and elsewhere in the body to reconstruct the removed breasts.

The term "Morgellons" was first used in 2002 when a woman named Mary Leiato noticed an alarming rash and ulcer around her young son's mouth. Although the disease has been dismissed by much of the mainstream medical community, a growing number of sufferers have emerged with alarming, often disfiguring, rashes and sores which they believe cannot be connected to other issues. Even so, sufferers are commonly told that the disease from which they are suffering is a product of their imagination.  A renowned pathologist and medical doctor, Dr. Karjoo has been at the forefront of the treatment and understanding of a condition which is also sometimes referred to as "Karjoo phenomenon."

Dr. Karjoo believes his concerns with silicone and silica are similar to those found in government reports, some from as far back as the early 1990s. These were issued by the Food & Drug Administration (FDA), which actually suggested that silicone implants be removed from the market, as well as by the Environmental Protection Agency (EPA) which was concerned about silica in the air and its impact on breathing. The Center for Disease Control (CDC) has also warned about the dangers of silica.

Aside from his research work, Dr. Karjoo has been working tirelessly with patients, many of whom have reported astonishing results with the therapies he has introduced to treat this devastating skin condition. In some cases, Dr. Karjoo reports complete reversal of the skin condition upon the removal of silicone breast implants.

SOURCE Rahim Karjoo , M.D., F.C.A.P., F.A.S.C.P.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer